Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals

被引:198
作者
Sedighi, Mansour [1 ]
Razavi, Shabnam [1 ,2 ]
Navab-Moghadam, Fatemeh [1 ]
Khamseh, Mohammad E. [3 ]
Alaei-Shahmiri, Fariba [4 ]
Mehrtash, Amirhosein [5 ]
Amirmozafari, Nour [1 ,2 ]
机构
[1] Iran Univ Med Sci, Sch Med, Dept Microbiol, Tehran 1439914153, Iran
[2] Iran Univ Med Sci, Microbial Biotechnol Res Ctr, Tehran, Iran
[3] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran
[4] Iran Univ Med Sci, Inst Endocrinol & Metab, Res Ctr Prevent Cardiovasc Dis, Tehran, Iran
[5] Pasteur Inst Iran, Biotechnol Res Ctr, Mol Med Dept, Tehran, Iran
关键词
Gut microbiota; Bacterial compositions; Type 2 diabetes mellitus; Metabolic syndrome; Real-time PCR; INTESTINAL MICROBIOTA; INSULIN-RESISTANCE; OBESITY; INFLAMMATION; BACTERIA; ASSOCIATION; RELIABILITY; METABOLISM; IMPACTS; ENERGY;
D O I
10.1016/j.micpath.2017.08.038
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent studies indicate that inflammatory reactions leading to the development of type 2 diabetes mellitus (T2DM) may also contribute to variations in the composition of the intestinal microbiota, suggesting a relation between T2DM and bacterial residents in the intestinal tract. This case-control study was designed to evaluate the composition of the gut microbiota dominant bacterial groups in patients with T2DM compared to the healthy people. A total of 36 adult subjects (18 patients diagnosed with T2DM and 18 healthy persons) were included in the study. The intestinal microbiota composition was investigated by quantitative real-time polymerase chain reaction (qPCR) method using bacterial 16S rRNA gene. The quantities of two groups of bacteria were meaningfully different among T2DM patients and healthy individuals. While, the level of Lactobacillus was significantly higher in the patients with T2DM (P value < 0.001), Bifidobacterium was significantly more frequent in the healthy people (P value < 0.001). The quantities of Prevotella (P value = 0.0.08) and Fusobacterium (P value = 0.99) genera in faecal samples were not significantly different between the two groups. The significant alterations in dominant faecal bacterial genera found in T2DM patients participating in the current study highlight the link between T2DM disease and compositional variation in intestinal flora. These findings may be valuable for developing approaches to control T2DM by modifying the gut microbiota. More investigations with focus on various taxonomic levels (family, genus and species) of bacteria are necessary to clarify the exact relevance of changes in the gut microbial communities with the progression of T2DM disorder. (C) 2017 Published by Elsevier Ltd.
引用
收藏
页码:362 / 369
页数:8
相关论文
共 50 条
  • [21] Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes
    Houghton, David
    Hardy, Timothy
    Stewart, Christopher
    Errington, Linda
    Day, Christopher P.
    Trenell, Michael I.
    Avery, Leah
    DIABETOLOGIA, 2018, 61 (08) : 1700 - 1711
  • [22] Modulation of gut microbiota by bioactive compounds for prevention and management of type 2 diabetes
    Sharma, Basista Rabina
    Jaiswal, Swarna
    Ravindra, P., V
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 152
  • [23] Current understanding on gut microbiota on insulin resistance and Type 2 diabetes mellitus
    Soomro, Samreen
    Alrashidi, Lama Saud
    Almutairi, Marah
    Obaidullah, Shatha
    RAWAL MEDICAL JOURNAL, 2025, 50 (01): : 205 - 210
  • [24] Effects of Smoking on the Gut Microbiota in Individuals with Type 2 Diabetes Mellitus
    Kondo, Yuriko
    Hashimoto, Yoshitaka
    Hamaguchi, Masahide
    Kaji, Ayumi
    Sakai, Ryosuke
    Inoue, Ryo
    Kashiwagi, Saori
    Mizushima, Katsura
    Uchiyama, Kazuhiko
    Takagi, Tomohisa
    Naito, Yuji
    Fukui, Michiaki
    NUTRIENTS, 2022, 14 (22)
  • [25] The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus
    Kootte, R. S.
    Vrieze, A.
    Holleman, F.
    Dallinga-Thie, G. M.
    Zoetendal, E. G.
    de Vos, W. M.
    Groen, A. K.
    Hoekstra, J. B. L.
    Stroes, E. S.
    Nieuwdorp, M.
    DIABETES OBESITY & METABOLISM, 2012, 14 (02) : 112 - 120
  • [26] Role of gut microbiota in the pathogenesis of type 2 diabetes mellitus (literature review)
    Koval, S. M.
    Snihurska, I. O.
    MEDICNI PERSPEKTIVI, 2021, 26 (04): : 22 - 30
  • [27] The Role of PPARγ Gene Polymorphisms, Gut Microbiota in Type 2 Diabetes: Current Progress and Future Prospects
    Zhao, Yi-Kun
    Zhu, Xiang-Dong
    Liu, Rong
    Yang, Xia
    Liang, Yong-Lin
    Wang, Yan
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 3557 - 3566
  • [28] Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes
    Caesar, Robert
    CANADIAN JOURNAL OF DIABETES, 2019, 43 (03) : 224 - 231
  • [29] Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
    Sircana, Antonio
    Framarin, Luciana
    Leone, Nicola
    Berrutti, Mara
    Castellino, Francesca
    Parente, Renato
    De Michieli, Franco
    Paschetta, Elena
    Musso, Giovanni
    CURRENT DIABETES REPORTS, 2018, 18 (10)
  • [30] Gut microbiota and immunopathogenesis of diabetes mellitus type 1 and 2
    Wang, Fei
    Zhang, Chunfang
    Zeng, Qiang
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2016, 21 : 900 - 906